Daniel Patrick O'Day - 10 Sep 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Edward S. Son by Power of Attorney for Daniel P. O'Day
Issuer symbol
GILD
Transactions as of
10 Sep 2024
Net transactions value
-$386,759
Form type
4
Filing time
11 Sep 2024, 19:30:22 UTC
Previous filing
11 Jun 2024
Next filing
11 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +10,295 +2.1% 500,744 10 Sep 2024 Direct F1
transaction GILD Common Stock Tax liability $386,759 -4,749 -0.95% $81.44 495,995 10 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -10,295 -8.2% 115,272 10 Sep 2024 Common Stock 10,295 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.